Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lipocine (LPCN) Cash from Operations (2016 - 2025)

Lipocine (LPCN) has disclosed Cash from Operations for 13 consecutive years, with 2985723.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash from Operations fell 5.39% year-over-year to 2985723.0, compared with a TTM value of 5139287.0 through Sep 2025, down 3.92%, and an annual FY2024 reading of 1221233.0, up 89.71% over the prior year.
  • Cash from Operations was 2985723.0 for Q3 2025 at Lipocine, down from 1886234.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 8994540.0 in Q4 2021 and bottomed at 6980787.0 in Q3 2021.
  • Average Cash from Operations over 5 years is 1910976.84, with a median of 2606032.0 recorded in 2023.
  • The sharpest move saw Cash from Operations skyrocketed 344.15% in 2021, then plummeted 181.8% in 2025.
  • Year by year, Cash from Operations stood at 8994540.0 in 2021, then plummeted by 120.44% to 1838914.0 in 2022, then fell by 9.97% to 2022305.0 in 2023, then surged by 184.16% to 1701927.0 in 2024, then tumbled by 275.43% to 2985723.0 in 2025.
  • Business Quant data shows Cash from Operations for LPCN at 2985723.0 in Q3 2025, 1886234.0 in Q2 2025, and 1969257.0 in Q1 2025.